Sexual Functioning After Primary Treatment of Ovarian Cancer
| Status: | Terminated |
|---|---|
| Conditions: | Ovarian Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | November 2004 |
| End Date: | November 2015 |
The purpose of this study is to help us learn more about sexual problems after treatment for
ovarian cancer. At this time, we do not know how many women have sexual problems after they
are treated for ovarian cancer.
How common are sexual problems after treatment for ovarian cancer?
- What factors make women more likely to have sexual problems after treatment for ovarian
cancer?
- What happens to sexual functioning over the first 12 months after treatment? ie.
Does it get better or worse?
• Does referral to a specialized sexual health clinic help?
ovarian cancer. At this time, we do not know how many women have sexual problems after they
are treated for ovarian cancer.
How common are sexual problems after treatment for ovarian cancer?
- What factors make women more likely to have sexual problems after treatment for ovarian
cancer?
- What happens to sexual functioning over the first 12 months after treatment? ie.
Does it get better or worse?
• Does referral to a specialized sexual health clinic help?
Inclusion Criteria:
- Women with any stage of invasive epithelial ovarian cancer who have completed
frontline therapy within the past 6 months
- Women must have no clinical evidence of disease
- At least 18 years of age
- English speaking
- Able to participate in the informed consent process
- Women who present to Sexual Health Clinic for the first time and meet all other
eligibility criteria are eligible. Their FSFI scores will be used to determine the
primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the
FSFI, they may still elect to be followed at the SHC.
Exclusion Criteria:
- Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment
- Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT,
PET scan etc) or physical examination
- Women with borderline (low malignant potential) ovarian cancers
- Women who are already in active evaluation and/or follow-up at the Sexual Health
Clinic
- Women with a history of prior whole pelvic radiation
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
